UNSPSC 51192006: Neocinchophen

This classification denotes a uricosuric agent and analgesic agent with the molecular formula C19H17NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 539M941Y9O, chemically known as 6-methylcinchophen, ethyl ester but generally known as neocinchophen, which bears US NIH Compound Identifier 68089. European Medicines Agency schedules Neocinchophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09194MIG.

UNSPSC 51192006 Neocinchophen is a Commodity code. The recent state and local opportunities tagged under this code show minimal alignment with the pharmaceutical scope implied by the code name. Instead, the sourced solicitations span athletic training services, police and fire department dog procurement, and medical aid supplies—none of which are neocinchophen or pharmaceutical products specifically. The code appears to serve as a catch-all or miscategorization point for health and safety services and supplies purchased by municipal fire departments, police departments, and city administrative offices rather than a dedicated pharmaceutical procurement category.

Geographic activity is concentrated in the Southwest and Pacific Northwest. Washington County, Oregon posted an RFP (RFP No. 2026.068-RFP) for a District Attorney's Office Dog due August 14, 2026; the City of Tucson, Arizona issued an RFP for comprehensive athletic training services for fire and police departments with a June 9, 2026 response deadline and non-mandatory pre-submittal meeting on May 19, 2026; and the City of Tampa, Florida solicited medical aid supplies through ITB 25-P-00157 with a $100,000 departmental budget and set-asides for Small Local Business Enterprises and Underutilized Woman and Minority Owned Business Enterprises offering bid discounts up to $20,000. The code shows no clear pattern of repeat buyers or concentrated activity in a single jurisdiction or service category, and the mismatch between the pharmaceutical code designation and the actual scope of recent opportunities suggests that this UNSPSC assignment may reflect data-entry errors or jurisdictional classification inconsistencies rather than genuine pharmaceutical procurement under the code.